Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis

Juan S. Lasa, Pablo A. Olivera, Stefanos Bonovas, Silvio Danese, Laurent Peyrin-Biroulet

Open source

DOI
10.1007/s40264-021-01057-z
Published
2021-03-05
Container
Drug Safety
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40264-021-01057-z,
  title = {Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis},
  author = {Juan S. Lasa and Pablo A. Olivera and Stefanos Bonovas and Silvio Danese and Laurent Peyrin-Biroulet},
  year = {2021},
  journal = {Drug Safety},
  doi = {10.1007/s40264-021-01057-z},
  url = {https://doi.org/10.1007/s40264-021-01057-z}
}

RIS

TY  - JOUR
TI  - Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis
AU  - Juan S. Lasa
AU  - Pablo A. Olivera
AU  - Stefanos Bonovas
AU  - Silvio Danese
AU  - Laurent Peyrin-Biroulet
PY  - 2021
JO  - Drug Safety
DO  - 10.1007/s40264-021-01057-z
UR  - https://doi.org/10.1007/s40264-021-01057-z
ER  - 

APA

Lasa, J. S., Olivera, P. A., Bonovas, S., Danese, S., & Peyrin-Biroulet, L. (2021). Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis. Drug Safety. https://doi.org/10.1007/s40264-021-01057-z

Source records